NCT02200822View on ClinicalTrials.gov

Systematic Withdrawal of Neurohumoral Blocker Therapy in Optimally Responding CRT Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

February 28, 2019

Study Completion Date

February 28, 2019

Conditions
Heart Failure (HF)
Interventions
DRUG

beta blockers

DRUG

RAAS blockers

RAAS blockers (combination of ACE-I/ARB and a mineralocorticoid receptor antagonist)

Trial Locations (1)

3600

Ziekenhuis Oost Limburg, Genk

All Listed Sponsors
collaborator

Ziekenhuis Oost-Limburg

OTHER

lead

Hasselt University

OTHER

NCT02200822 - Systematic Withdrawal of Neurohumoral Blocker Therapy in Optimally Responding CRT Patients | Biotech Hunter | Biotech Hunter